Kayleigh A. Swaggart, Ph.D.
Affiliations: | 2013 | Human Genetics | University of Chicago, Chicago, IL |
Area:
GeneticsGoogle:
"Kayleigh Swaggart"Parents
Sign in to add mentor| Elizabeth M. McNally | grad student | 2013 | Chicago | |
| (Modifiers of cardiopulmonary involvement in muscular dystrophy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vo AH, Swaggart KA, Woo A, et al. (2018) Dusp6 is a genetic modifier of growth through enhanced ERK activity. Human Molecular Genetics |
| Lee YS, Lehar A, Sebald S, et al. (2015) Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy. Human Molecular Genetics |
| Gardner BB, Swaggart KA, Kim G, et al. (2015) Cardiac function in muscular dystrophy associates with abdominal muscle pathology. Journal of Neuromuscular Diseases. 2: 39-49 |
| Swaggart KA, Demonbreun AR, Vo AH, et al. (2014) Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proceedings of the National Academy of Sciences of the United States of America. 111: 6004-9 |
| Swaggart KA, McNally EM. (2014) Modifiers of heart and muscle function: where genetics meets physiology. Experimental Physiology. 99: 621-6 |
| Heydemann A, Swaggart KA, Kim GH, et al. (2012) The superhealing MRL background improves muscular dystrophy. Skeletal Muscle. 2: 26 |
| Swaggart KA, Heydemann A, Palmer AA, et al. (2011) Distinct genetic regions modify specific muscle groups in muscular dystrophy. Physiological Genomics. 43: 24-31 |
| Demonbreun AR, Posey AD, Heretis K, et al. (2010) Myoferlin is required for insulin-like growth factor response and muscle growth. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 1284-95 |